201 E Sample Rd, Deerfield Beach, FL, 33064 · (954) 786-6400
Beds
304
FY 2025
Star rating
3 of 5
Patient survey: 2 of 5
Net patient revenue
$336.3M
FY 2025
Net income
$42.7M
Patient care margin -8.1%
Discharges
11,758
Occupancy 60.6%
Clinicians
390
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $336.3M | $363.6M | -8.1% | $42.7M | 11,758 | $34.7M | 20.0% | 1.9% |
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
| Death rate for COPD patients | 7.7% | US median 8.5% |
| Death rate for heart attack patients | 13.3% | US median 11.8% |
| Death rate for heart failure patients | 8.6% | US median 11% |
| Hospital-wide death rate within 30 days | 3.9% | US median 3.9% |
| Death rate for pneumonia patients | 14.6% | US median 15.2% |
| Death rate for stroke patients | 11.1% | US median 11.6% |
Medicare clinicians who list this hospital, by specialty
Inpatient stays by diagnosis related group (DRG), 2024
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
Medicare clinicians who work here
| 2024 | $303.0M | $325.6M | -7.5% | $39.4M | 11,048 | $33.9M | 19.9% | 2.9% |
| 2023 | $254.1M | $297.8M | -17.2% | $11.2M | 10,284 | $29.7M | 20.6% | 4.6% |
| 2022 | $263.6M | $326.7M | -24.0% | -$13.4M | 11,251 | $40.1M | 20.1% | 7.2% |
| 2021 | $220.1M | $258.9M | -17.6% | $14.1M | 12,033 | $33.3M | 21.6% | 6.6% |
| 2020 | $208.1M | $255.5M | -22.8% | $17.8M | 12,639 | $28.6M | 25.0% | 9.6% |
| Readmission rate for COPD | 21.2% | US median 19.8% |
| Readmission rate after a heart attack | 14% | US median 14.4% |
| Readmission rate for heart failure | 21.6% | US median 21.3% |
| Readmission rate after hip or knee replacement | 5.5% | US median 5.8% |
| Readmission rate for pneumonia | 17.8% | US median 17.2% |
| Complications after hip or knee replacement | 5% | US median 4.1% |
| Serious complications (patient safety composite) | 1.05 | US median 0.96 |
| C. diff intestinal infections (ratio to expected) | 0.02 | US median 0.28 · better |
| Central line bloodstream infections (ratio to expected) | 0.23 | US median 0.48 · better |
| Surgical site infections after colon surgery (ratio to expected) | 1.65 | US median 0.72 |
| MRSA bloodstream infections (ratio to expected) | 0.48 | US median 0.60 |
| Catheter urinary tract infections (ratio to expected) | 0.15 | US median 0.40 · better |
| Doctors always communicated well | 71% | US median 79% |
| Nurses always communicated well | 74% | US median 80% |
| Patient survey summary star rating | 2 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 46% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 67% | US median 72% |
| Room and bathroom always clean | 66% | US median 73% |
| Patients who would definitely recommend the hospital | 65% | US median 71% |
| Patients who left the emergency department before being seen | 0% | US median 1% |
| Median time in the emergency department before leaving (minutes) | 187 min | US median 148 min |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 15% | US median 15% |
| Patients who got appropriate care for severe sepsis and septic shock | 65% | US median 65% |
| Healthcare workers given the flu vaccine | 86% | US median 79% |
| 55 |
| $84,490.15 |
| $15,002.78 |
| $15,801.33 |
| DRG 683 RENAL FAILURE WITH CC | 51 | $35,345.69 | $7,292.24 | $6,629.69 |
| DRG 690 KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MCC | 51 | $33,468.73 | $6,913.00 | $5,985.69 |
| DRG 682 RENAL FAILURE WITH MCC | 50 | $53,901.60 | $10,690.20 | $11,457.18 |
| DRG 064 INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MCC | 47 | $107,651.98 | $14,263.68 | $15,695.20 |
| DRG 641 MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITHOUT MCC | 46 | $31,586.54 | $6,881.98 | $5,829.71 |
| DRG 312 SYNCOPE AND COLLAPSE | 46 | $32,819.72 | $7,389.00 | $6,636.32 |
| DRG 177 RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MCC | 45 | $72,460.20 | $12,898.47 | $12,667.88 |
| DRG 698 OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MCC | 44 | $73,285.25 | $14,110.14 | $13,076.55 |
| DRG 552 MEDICAL BACK PROBLEMS WITHOUT MCC | 41 | $43,965.66 | $7,540.90 | $7,114.44 |
| DRG 689 KIDNEY AND URINARY TRACT INFECTIONS WITH MCC | 37 | $40,331.03 | $9,446.00 | $8,838.11 |
| DRG 392 ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MCC | 35 | $31,792.26 | $6,577.91 | $5,662.18 |
| DRG 640 MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITH MCC | 34 | $45,366.44 | $9,970.09 | $10,642.23 |
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 8011 Comprehensive Observation Services | 513 | 465 | $1,913.91 | $2,090.36 |
| APC 5115 Level 5 Musculoskeletal Procedures | 276 | 270 | $10,003.04 | $10,771.69 |
| APC 5183 Level 3 Vascular Procedures | 30 | 27 | $2,241.41 | $2,405.01 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | 29 | 19 | $1,125.75 | $1,219.56 |
| APC 5184 Level 4 Vascular Procedures | 25 | 22 | $3,881.57 | $3,945.82 |
| APC 5492 Level 2 Intraocular Procedures | 21 | 19 | $2,868.48 | $3,116.50 |
| APC 5191 Level 1 Endovascular Procedures | 21 | 21 | $2,075.97 | $2,207.96 |
| APC 5193 Level 3 Endovascular Procedures | 18 | 18 | $7,680.59 | $8,873.86 |
| APC 5112 Level 2 Musculoskeletal Procedures | 16 | 16 | $1,126.06 | $1,196.16 |
| APC 5302 Level 2 Upper GI Procedures | 16 | 16 | $1,348.48 | $1,444.50 |
| APC 5182 Level 2 Vascular Procedures | 15 | 15 | $1,133.42 | $1,204.32 |
| APC 5113 Level 3 Musculoskeletal Procedures | 15 | 15 | $2,290.74 | $2,373.24 |
Reported payments to this teaching hospital
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Broward Health North is a government-owned short-term acute care hospital in Deerfield Beach, FL with 304 beds, part of Broward Health and a 3-star overall rating.
Broward Health North in Deerfield Beach, FL has 304 beds (fiscal year 2025 cost report); 409 beds are certified for Medicare. It discharged 11,758 inpatients that year, with 60.6% of its beds in use on average.
In fiscal year 2025 (ending 2025-06-30), Broward Health North reported net patient revenue of $336.3M and operating expenses of $363.6M, a margin on patient care of -8.1%. After other income and expenses its net income was $42.7M (10.5% of revenue), so it made a profit that year.
Broward Health North is part of Broward Health, a health system with 4 hospitals based in Ft. Lauderdale, FL. It is a government-owned hospital.
Broward Health North has an overall rating of 3 out of 5 stars in the official hospital quality ratings. Patients rate it 2 out of 5 stars in the patient survey.
Yes, Broward Health North provides emergency services.
390 Medicare clinicians list Broward Health North as a hospital they work at, most often in Internal Medicine, Certified Registered Nurse Anesthetist (Crna), Diagnostic Radiology.
In 2024, Broward Health North had 1,756 Medicare inpatient stays in 60 diagnosis groups. The most common was DRG 871 (septicemia or severe sepsis without mv >96 hours with mcc) with 259 stays; Medicare paid $14,599.30 per stay on average, compared with $15,524.21 across all hospitals.
In 2025, companies reported $33K in payments to Broward Health North as a teaching hospital ($5,000 general and $28K for research) from 2 companies.